Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 12/2020

01-12-2020 | Review Article

The new function of circRNA: translation

Authors: Y. Shi, X. Jia, J. Xu

Published in: Clinical and Translational Oncology | Issue 12/2020

Login to get access

Abstract

Circular RNAs (circRNAs) have been considered a special class of non-coding RNAs without 5′ caps and 3′ tails which are covalently closed RNA molecules generated by back splicing of mRNA. For a long time, circRNAs have been considered to be directly involved in various biological processes as functional RNA. In recent years, a variety of circRNAs have been found to have translational functions, and the resultant peptides also play biological roles in the emergence and progression of human disease. The discovery of these circRNAs and their encoded peptides has enriched genomics, helped us to study the causes of diseases, and promoted the development of biotechnology. The purpose of this review is to summarize the research progress of the detection methods, translation initiation mechanism, as well as functional mechanism of peptides encoded by circRNAs, with the goal of providing the directions for the discovery of biomarkers for diagnosis, prognosis, and therapeutic targets for human disease.
Literature
1.
2.
Chekulaeva M Rajewsky N. Roles of long noncoding RNAs and circular RNAs in Translation. Cold Spring Harb Perspect Biol. 2019;11:a032680.PubMedPubMedCentral
3.
Sanger HL, Klotz G, Riesner D, et al. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci USA. 1976;73:3852–6.PubMedPubMedCentral
4.
Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19:141–57.PubMedPubMedCentral
5.
6.
Zhang Y, Zhang XO, Chen T, et al. Circular intronic long noncoding RNAs. Mol Cell. 2013;51:792–806.PubMed
7.
Zganiacz D, Milanowski R. Characteristics of circular ribonucleic acid molecules (circRNA). Postepy Biochem. 2017;63:221–32.PubMed
8.
Chen N, Zhao G, Yan X, et al. A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1. Genome Biol. 2018;19:218.PubMedPubMedCentral
9.
Li Z, Huang C, Bao C, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22:256–64.PubMed
10.
Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333–8.PubMed
11.
Conn VM, Hugouvieux V, Nayak A, et al. A circRNA from SEPALLATA3 regulates splicing of its cognate mRNA through R-loop formation. Nat Plants. 2017;3:17053.PubMed
12.
Fu L, Chen Q, Yao T, et al. Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma. Oncotarget. 2017;8:43878–88.PubMedPubMedCentral
13.
Chen L, Zhang S, Wu J, et al. CircRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family. Oncogene. 2017;36:4551–61.PubMedPubMedCentral
14.
Han D, Li J, Wang H, et al. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology. 2017;66:1151–64.PubMed
15.
Du WW, Yang W, Liu E, et al. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2. Nucleic Acids Res. 2016;44:2846–58.PubMedPubMedCentral
16.
Du WW, Fang L, Yang W, et al. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death Differ. 2017;24:357–70.PubMed
17.
Bi W, Huang J, Nie C, et al. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of β-catenin pathway. J Exp Clin Cancer Res. 2018;37:275.PubMedPubMedCentral
18.
Chang CY, Sarnow P. Initiation of protein synthesis by the eukaryotic. Transl Appar Circ RNAs Sci. 1995;268:415–7.
19.
Xia X, Li X, Li F, et al. A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1. Mol Cancer. 2019;18:131.PubMedPubMedCentral
20.
Zheng X, Chen L, Zhou Y, et al. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling. Mol Cancer. 2019;18:47.PubMedPubMedCentral
21.
Zhang M, Huang N, Yang X, et al. A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis. Oncogene. 2019;37:1805–14.
22.
Yang Y, Gao X, Zhang M, et al. Novel role of FBXW7 circular RNA in Repressing glioma tumorigenesis. J Natl Cancer Inst. 2018;110:304–15.
23.
Zhang M, Zhao K, Xu X, et al. A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma. Nat Commun. 2018;9:4475.PubMedPubMedCentral
24.
Legnini L, Di Timoteo G, Rossi F, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol Cell. 2017;66:22–37.PubMedPubMedCentral
25.
Zhao J, Lee EE, Kim J, et al. Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus. Nat Commun. 2019;10:2300.PubMedPubMedCentral
26.
Liang WC, Wong CW, Liang PP, et al. Translation of the circular RNA circβ-catenin promotes liver cancer cell growth through activation of the Wnt pathway. Genome Biol. 2019;20:84.PubMedPubMedCentral
27.
Banko JL, Klann E. Cap-dependent translation initiation and memory. Prog Brain Res. 2008;169:59–80.PubMed
28.
Sonenberg N, Hinnebusch AG. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell. 2009;136:731–45.PubMedPubMedCentral
29.
Merrick WC. Cap-dependent and cap-independent translation in eukaryotic systems. Gene. 2004;332:1–11.PubMed
30.
Yang Y, Fan X, Mao M, et al. Extensive translation of circular RNAs driven by N6-methyladenosine. Cell Res. 2017;27:626–41.PubMedPubMedCentral
31.
Gu C, Zhou N, Wang Z, et al. CircGprc5a promoted bladder oncogenesis and metastasis through Gprc5a-targeting peptide. Mol Ther Nucleic Acids. 2018;13:633–41.PubMedPubMedCentral
32.
33.
Imataka H, Olsen HS, Sonenberg N. A new translational regulator with homology to eukaryotic translation initiation factor 4G. EMBO J. 1997;16:817–25.PubMedPubMedCentral
34.
Morino S, Imataka H, Svitkin YV, et al. Eukaryotic translation initiation factor 4E (eIF4E) binding site and the middle one-third of eIF4GI constitute the core domain for cap- dependent translation, and the C-terminal one-third functions as a modulatory region. Mol Cell Biol. 2000;20:468–77.PubMedPubMedCentral
35.
Liberman N, Gandin V, Svitkin YV, et al. DAP5 associates with eIF2β and eIF4AI to promote internal ribosome entry site driven translation. Nucleic Acids Res. 2015;43:3764–75.PubMedPubMedCentral
36.
Lamphear BJ, Kirchweger R, Skern T, et al. Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. Implications for cap-dependent and cap-independent translational initiation. J Biol Chem. 1995;270:21975–83.PubMed
37.
Hellen CU, Sarnow P. Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev. 2001;15:1593–612.PubMed
38.
Kearse MG, Wilusz JE. Non-AUG translation: a new start for protein synthesis in eukaryotes. Genes Dev. 2017;31:1717–31.PubMedPubMedCentral
39.
Abe N, Hiroshima M, Maruyama H, et al. Rolling circle amplification in a prokaryotic translation system using small circular RNA. Angew Chem Int Ed Engl. 2013;52:7004–8.PubMed
40.
Abe N, Matsumoto K, Nishihara M, et al. Rolling circle translation of circular RNA in living human cells. Sci Rep. 2015;5:16435.PubMedPubMedCentral
41.
Warner JR, Knopf PM, Rich A. A multiple ribosomal structure in protein synthesis. Proc Natl Acad Sci USA. 1963;49:122–9.PubMedPubMedCentral
42.
Chassé H, Boulben S, Costache V, et al. Analysis of translation using polysome profiling. Nucleic Acids Res. 2017;45:e15.PubMed
43.
Ingolia NT, Ghaemmaghami S, Newman JR, et al. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science. 2009;324:218–23.PubMedPubMedCentral
44.
Ingolia NT, Brar GA, Rouskin S, et al. The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments. Nat Protoc. 2012;7:1534–50.PubMedPubMedCentral
45.
Dudekula DB, Panda AC, Grammatikakis I, et al. CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2016;13:34–42.PubMed
46.
Wang J, Gribskov M. IRESpy: an XGBoost model for prediction of internal ribosome entry sites. BMC Bioinformatics. 2019;20:409.PubMedPubMedCentral
47.
Zhao J, Wu J, Xu T, et al. IRESfinder: identifying RNA internal ribosome entry site in eukaryotic cell using framed K-mer features. J Genet Genomics. 2018;45:403–6.PubMed
48.
Dominissini D, Moshitch-Moshkovitz S, Schwartz S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485:201–6.PubMed
49.
Molinie B, Giallourakis CC. Genome-wide location analyses of N6-methyladenosine modifications (m6A-Seq). Methods Mol Biol. 2017;1562:45–53.PubMedPubMedCentral
50.
Plaza S, Menschaert G, Payre F. In search of lost small peptides. Annu Rev Cell Dev Biol. 2017;33:391–416.PubMed
51.
Meng X, Chen Q, Zhang P, et al. CircPro: an integrated tool for the identification of circRNAs with protein-coding potential. Bioinformatics. 2017;33:3314–6.PubMed
52.
53.
Spriggs KA, Stoneley M, Bushell M, et al. Reprogramming of translation following cell stress allows IRES-mediated translation to predominate. Biol Cell. 2008;100:27–38.PubMed
54.
55.
Mo D, Li X, Raabe CA, et al. A universal approach to investigate circRNA protein coding function. Sci Rep. 2019;9:11684.PubMedPubMedCentral
Metadata
Title
The new function of circRNA: translation
Authors
Y. Shi
X. Jia
J. Xu
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 12/2020
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-020-02371-1

Other articles of this Issue 12/2020

Clinical and Translational Oncology 12/2020 Go to the issue

Review Article

Latest progress in molecular biology and treatment in genitourinary tumours

Research Article

The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database

Research Article

FAM83H overexpression predicts worse prognosis and correlates with less CD8+ T cells infiltration and Ras-PI3K-Akt-mTOR signaling pathway in pancreatic cancer

Review Article

Potential biomarkers for early detection of pancreatic ductal adenocarcinoma

Review Article

Research progress of tumor microenvironment and tumor-associated macrophages

Research Article

Potential roles of lymphovascular space invasion based on tumor characteristics provide important prognostic information in T1 tumors with ER and HER2 positive breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits